Diagnostic Medical Systems SA
PAR:ALDMS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Diagnostic Medical Systems SA
PAR:ALDMS
|
FR |
|
F
|
First National Corp
NASDAQ:FXNC
|
US |
|
MacroGenics Inc
NASDAQ:MGNX
|
US |
|
Melrose Industries PLC
LSE:MRO
|
UK |
|
Quinstreet Inc
NASDAQ:QNST
|
US |
|
Open Lending Corp
NASDAQ:LPRO
|
US |
|
N
|
NVIDIA Corp
DUS:NVD
|
US |
|
S
|
Standard Bank Group Ltd
XMUN:SKC2
|
ZA |
|
B
|
Burberry Group PLC
DUS:BB2
|
UK |
|
Pacific Biosciences of California Inc
NASDAQ:PACB
|
US |
|
Svenska Cellulosa SCA AB
LSE:0MCK
|
SE |
|
Intellect Design Arena Ltd
NSE:INTELLECT
|
IN |
|
D
|
Deutsche Telekom AG
F:DTE
|
DE |
|
W
|
Weyerhaeuser Co
F:WHC
|
US |
|
Fleury Michon SA
PAR:ALFLE
|
FR |
|
Vicinity Centres
ASX:VCX
|
AU |
|
Allbirds Inc
NASDAQ:BIRD
|
US |
|
Mind Medicine (MindMed) Inc
F:MMQ
|
US |
|
Q
|
QL Resources Bhd
KLSE:QL
|
MY |
|
Lar Espana Real Estate SOCIMI SA
MAD:LRE
|
ES |
|
M
|
Mitsubishi Gas Chemical Co Inc
XBER:MUG
|
JP |
|
Nordic American Tanker Ltd
NYSE:NAT
|
BM |
|
Freeport-McMoRan Inc
NYSE:FCX
|
US |
|
V
|
Verbund AG
VSE:VER
|
AT |
Wall St Price Targets
ALDMS Price Targets Summary
Diagnostic Medical Systems SA
According to Wall Street analysts, the average 1-year price target for ALDMS is 2.14 EUR with a low forecast of 2.02 EUR and a high forecast of 2.31 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ALDMS's stock price target?
Price Target
2.14
EUR
According to Wall Street analysts, the average 1-year price target for ALDMS is 2.14 EUR with a low forecast of 2.02 EUR and a high forecast of 2.31 EUR.
What is the Revenue forecast for Diagnostic Medical Systems SA?
Projected CAGR
12%
Over the last 8 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is 12%.
What is the Operating Income forecast for Diagnostic Medical Systems SA?
Projected CAGR
76%
The compound annual growth rate for Operating Income over the next 3 years is 76%.
